123 related articles for article (PubMed ID: 19161534)
1. Immunohistochemical analysis of Fas and FLIP in prostate cancers.
Kim SY; Song SY; Kim MS; Lee JY; Lee HM; Choi HY; Yoo NJ; Lee SH
APMIS; 2009 Jan; 117(1):28-33. PubMed ID: 19161534
[TBL] [Abstract][Full Text] [Related]
2. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
3. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
5. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma.
Zhou XD; Yu JP; Liu J; Luo HS; Chen HX; Yu HG
Clin Sci (Lond); 2004 Apr; 106(4):397-405. PubMed ID: 14636156
[TBL] [Abstract][Full Text] [Related]
7. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
[TBL] [Abstract][Full Text] [Related]
9. The FAS-related apoptosis signaling pathway in the prostate intraepithelial neoplasia and cancer lesions.
Drewa T; Wolski Z; Skok Z; Czajkowski R; Wiśniewska H
Acta Pol Pharm; 2006; 63(4):311-5. PubMed ID: 17203870
[TBL] [Abstract][Full Text] [Related]
10. Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.
Yoo NJ; Lee SH; Jeong EG; Lee JW; Soung YH; Nam SW; Kim SH; Lee JY; Lee SH
Pathol Res Pract; 2007; 203(2):73-8. PubMed ID: 17207586
[TBL] [Abstract][Full Text] [Related]
11. Critical role for c-FLIP(L) on Fas resistance in colon carcinoma cell line HT-29.
Zang F; Sun B; Zhao X; Niu R; Zhang S; Yu M; Wei X; Zhang L
Cell Biol Int; 2008 Mar; 32(3):329-36. PubMed ID: 18243739
[TBL] [Abstract][Full Text] [Related]
12. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of AMP-activated protein kinase sensitizes DU145 carcinoma to Fas-induced apoptosis via c-FLIP degradation.
Jung SN; Park IJ; Kim MJ; Kang I; Choe W; Kim SS; Ha J
Exp Cell Res; 2009 Aug; 315(14):2433-41. PubMed ID: 19477172
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes.
Huo J; Xu S; Guo K; Zeng Q; Lam KP
Cell Death Differ; 2009 Jul; 16(7):1062-70. PubMed ID: 19300454
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Krajewska M; Krajewski S; Banares S; Huang X; Turner B; Bubendorf L; Kallioniemi OP; Shabaik A; Vitiello A; Peehl D; Gao GJ; Reed JC
Clin Cancer Res; 2003 Oct; 9(13):4914-25. PubMed ID: 14581366
[TBL] [Abstract][Full Text] [Related]
16. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis.
Monteleone I; Monteleone G; Fina D; Caruso R; Petruzziello C; Calabrese E; Biancone L; Pallone F
Gastroenterology; 2006 Feb; 130(2):389-97. PubMed ID: 16472594
[TBL] [Abstract][Full Text] [Related]
17. SBDS-deficiency results in specific hypersensitivity to Fas stimulation and accumulation of Fas at the plasma membrane.
Watanabe K; Ambekar C; Wang H; Ciccolini A; Schimmer AD; Dror Y
Apoptosis; 2009 Jan; 14(1):77-89. PubMed ID: 19009351
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.
Lee SW; Cho JM; Cho HJ; Kang JY; Kim EK; Yoo TK
Korean J Urol; 2015 Jul; 56(7):505-14. PubMed ID: 26175869
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant status alters levels of Fas-associated death domain-like IL-1B-converting enzyme inhibitory protein following neonatal hypoxia-ischemia.
Payton KS; Sheldon RA; Mack DW; Zhu C; Blomgren K; Ferriero DM; Northington FJ
Dev Neurosci; 2007; 29(4-5):403-11. PubMed ID: 17762208
[TBL] [Abstract][Full Text] [Related]
20. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
